Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Tower One September Update


Posted on: 06 Sep 18

VANCOUVER, British Columbia, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N) (“Tower One” or the “Company”) announces a comprehensive update on recent company milestones throughout Argentina, Colombia, and Mexico. The Company now has a total of fifty (50) In-Service towers throughout Argentina and Colombia with fifteen (15) collocations hosting an additional tenant; and thirty -five (35) additional towers are now under construction. Tower One has a backlog of four hundred and ninety (490) sites awarded for Build to Suit “BTS”.

CountryIn-Service
Towers
CollocationsTenantsTowers Under
Construction
Tower
Backlog
Argentina38125025350
Colombia123151080
Mexico----60
Total50156535490

Alejandro Ochoa, CEO of Tower One, states: “We are pleased with the number of collocations in the first 18 months of operations in Argentina. In addition, we welcome the increase in the Mexico backlog that now provides the company with a larger diversification in our principal markets of focus.”

About Tower One Wireless Corp.
Tower One Wireless Corp. is a pure-play, build-to-suit tower owner, operator and developer of multitenant communications real estate. The Company’s primary business is the leasing of space on communications sites to mobile network operators (“MNOs”). The Company offers tower-related services in the largest Spanish speaking countries in Latin America: Argentina, Colombia and Mexico.

Contact Information 
USA  (917) 546-3016
E-mail:  info@toweronewireless.com
Website:  www.toweronewireless.com

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of the contents of this news release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the U.S. Securities Act), or any state securities law and may not be offered or sold in the United States, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

GlobeNewswire
globenewswire.com

Last updated on: 06/09/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.